QT
RCUS icon

Quantbot Technologies’s Arcus Biosciences RCUS Stock Holding History

Quantbot Technologies’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300
Closed -$6.09K – 1889
2023
Q2 		$6.09K Buy
+300
New +$5.71K ﹤0.01% 1488
2021
Q4 		– Sell
-2,000
Closed -$69K – 1841
2021
Q3 		$69K Buy
+2,000
New +$62.2K 0.01% 1053
2021
Q2 		– Sell
-237
Closed -$6K – 1792
2021
Q1 		$6K Buy
+237
New +$8.25K ﹤0.01% 1286
2020
Q4 		– Sell
-500
Closed -$8K – 1612
2020
Q3 		$8K Buy
+500
New +$11.2K ﹤0.01% 1140

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Quantbot Technologies's RCUS Position: Q3 2023 in Review

Quantbot Technologies sold out of Arcus Biosciences (RCUS) in Q3 2023, closing a stake of 300 shares — an estimated $6.09K sold.

Quantbot Technologies first reported a position in RCUS in Q3 2020 and held it in 4 quarters. The position peaked at $69K in Q3 2021. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2023.

  • Quantbot Technologies reported no remaining Arcus Biosciences position as of Q3 2023 after selling out during the quarter.
  • Quantbot Technologies sold 300 Arcus Biosciences shares in Q3 2023, an estimated $6.09K.
  • Quantbot Technologies first reported a position in Arcus Biosciences in Q3 2020 and held it in 4 quarters.
  • Quantbot Technologies's Arcus Biosciences position peaked at $69K in Q3 2021.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2023.

Based on Quantbot Technologies's 13F filing for Q3 2023, filed 7 Nov 2023.